Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Laxmi Banjare, Yogesh Singh, Sant Kumar Verma, Atul Kumar Singh, Pradeep Kumar, Shashank Kumar, Akhlesh Kumar Jain & Suresh Thareja. (2023) Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors. Journal of Biomolecular Structure and Dynamics 41:4, pages 1322-1341.
Read now
Read now
Articles from other publishers (45)
Debashis Ghosh. (2023) Structures and functions of human placental aromatase and steroid sulfatase, two key enzymes in estrogen biosynthesis. Steroids 196, pages 109249.
Crossref
Crossref
Borja Diaz de Greñu, Diego M. Fernández-Aroca, Juan A. Organero, Gema Durá, Felix Angel Jalón, Ricardo Sánchez-Prieto, M. José Ruiz-Hidalgo, Ana María Rodríguez, Lucia Santos, José L. Albasanz & Blanca R. Manzano. (2023) Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents. JBIC Journal of Biological Inorganic Chemistry 28:6, pages 531-547.
Crossref
Crossref
Yongmei Wang, Fanbo Jing & Haibo Wang. (2022) Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence. Advances in Therapy 39:2, pages 862-891.
Crossref
Crossref
Nilanjan Adhikari, Sandip Kumar Baidya & Tarun Jha. (2020) Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors. European Journal of Medicinal Chemistry 208, pages 112845.
Crossref
Crossref
Mahboobeh Kian & Elham Tazikeh-Lemeski. (2020) B12Y12 (Y: N, P) fullerene-like cages for exemestane-delivery; molecular modeling investigation. Journal of Molecular Structure 1217, pages 128455.
Crossref
Crossref
Laxmi Banjare, Sant Kumar Verma, Akhlesh Kumar Jain & Suresh Thareja. (2020) Design and pharmacophoric identification of flavonoid scaffold‐based aromatase inhibitors. Journal of Heterocyclic Chemistry.
Crossref
Crossref
Mei Jiang, Weiling Wang, Jingxuan Zhang, Chunguo Wang, Yucong Bi, Pin Li, Song Yang, Jialin Li, Yan-Tong Xu & Ting Wang. (2020) Protective Effects and Possible Mechanisms of Actions of Bushen Cuyun Recipe on Diminished Ovarian Reserve Induced by Cyclophosphamide in Rats. Frontiers in Pharmacology 11.
Crossref
Crossref
Subhajit Makar, Abhrajyoti Ghosh, Ashok Kumar & Sushil K. Singh. (2020) Recent Studies on Aromatase and Sulfatase Involved in Breast Cancer and their Inhibitors. Current Enzyme Inhibition 16:1, pages 20-44.
Crossref
Crossref
Mark Gray, James Meehan, Carlos Martínez-Pérez, Charlene Kay, Arran K. Turnbull, Linda R. Morrison, Lisa Y. Pang & David Argyle. (2020) Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Laxmi Banjare, Sant Kumar Verma, Akhlesh Kumar Jain & Suresh Thareja. (2019) Structure Guided Molecular Docking Assisted Alignment Dependent 3DQSAR Study on Steroidal Aromatase Inhibitors (SAIs) as Anti-breast Cancer Agents. Letters in Drug Design & Discovery 16:7, pages 808-817.
Crossref
Crossref
Rebeka Jójárt, Péter Traj, Édua Kovács, Ágnes Horváth, Gyula Schneider, Mihály Szécsi, Attila Pál, Gábor Paragi & Erzsébet Mernyák. (2019) Synthesis, Biological Evaluation and Docking Studies of 13-Epimeric 10-fluoro- and 10-Chloroestra-1,4-dien-3-ones as Potential Aromatase Inhibitors. Molecules 24:9, pages 1783.
Crossref
Crossref
Irida Kastrati, Svetlana Semina, Benjamin Gordon & Emily Smart. (2019) Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer. Molecular and Cellular Endocrinology 483, pages 97-101.
Crossref
Crossref
Irida Kastrati. 2017. Resistance to Targeted Therapies in Breast Cancer. Resistance to Targeted Therapies in Breast Cancer
89
101
.
Mahder Seifu Manenda, Charles Jérémie Hamel, Loreleï Masselot--Joubert, Marie-Ève Picard & Rong Shi. (2016) Androgen-metabolizing enzymes: A structural perspective. The Journal of Steroid Biochemistry and Molecular Biology 161, pages 54-72.
Crossref
Crossref
Debashis Ghosh, Jessica Lo & Chinaza Egbuta. (2016) Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure–Function Perspective. Journal of Medicinal Chemistry 59:11, pages 5131-5148.
Crossref
Crossref
Mange Ram Yadav, Mahesh A. Barmade, Riyaj S. Tamboli & Prashant R. Murumkar. (2015) Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer. European Journal of Medicinal Chemistry 105, pages 1-38.
Crossref
Crossref
Irshad Ahmad & Shagufta. (2015) Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. European Journal of Medicinal Chemistry 102, pages 375-386.
Crossref
Crossref
Yunlong Wu & Zhiyi Yao. (2015) Synthesis, Biological Evaluation and Molecular Docking Studies of Ferrocene Derivatives Coupling with N-heterocyclic on Human Breast Cancer. MATEC Web of Conferences 22, pages 05001.
Crossref
Crossref
Debashis Ghosh, Jessica Lo & Chinaza Egbuta. 2015. Resistance to Aromatase Inhibitors in Breast Cancer. Resistance to Aromatase Inhibitors in Breast Cancer
33
61
.
Chinaza Egbuta, Jessica Lo & Debashis Ghosh. (2014) Mechanism of Inhibition of Estrogen Biosynthesis by Azole Fungicides. Endocrinology 155:12, pages 4622-4628.
Crossref
Crossref
Samar BasuRachida Nachat-KappesFlorence Caldefie-ChézetMarie-Paule Vasson. (2013) Eicosanoids and Adipokines in Breast Cancer: From Molecular Mechanisms to Clinical Considerations. Antioxidants & Redox Signaling 18:3, pages 323-360.
Crossref
Crossref
Debashis Ghosh, Jessica Lo, Daniel Morton, Damien Valette, Jingle Xi, Jennifer Griswold, Susan Hubbell, Chinaza Egbuta, Wenhua Jiang, Jing An & Huw M. L. Davies. (2012) Novel Aromatase Inhibitors by Structure-Guided Design. Journal of Medicinal Chemistry 55:19, pages 8464-8476.
Crossref
Crossref
Aruna V. Krishnan, Srilatha Swami & David Feldman. (2012) The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids 77:11, pages 1107-1112.
Crossref
Crossref
Marzia Del Re, Angela Michelucci, Paolo Simi & Romano Danesi. (2012) Pharmacogenetics of anti-estrogen treatment of breast cancer. Cancer Treatment Reviews 38:5, pages 442-450.
Crossref
Crossref
Hareesh B. Nair, Rao P. Perla, Nameer B. Kirma, Naveen K. Krishnegowda, Manonmani Ganapathy, Rajib Rajhans, Sujit S. Nair, Pothana Saikumar, Ratna K. Vadlamudi & Rajeshwar Rao Tekmal. (2011) Estrogen Receptor-beta Mediates the Protective Effects of Aromatase Induction in the MMTV-Her-2/neu x Aromatase Double Transgenic Mice. Hormones and Cancer 3:1-2, pages 26-36.
Crossref
Crossref
Debashis Ghosh, Wenhua Jiang, Jessica Lo & Chinaza Egbuta. (2011) Higher order organization of human placental aromatase. Steroids 76:8, pages 753-758.
Crossref
Crossref
Karen A. Johnson & Powel H. Brown. (2010) Drug Development for Cancer Chemoprevention: Focus on Molecular Targets. Seminars in Oncology 37:4, pages 345-358.
Crossref
Crossref
Aruna V. Krishnan, Srilatha Swami & David Feldman. (2010) Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling. The Journal of Steroid Biochemistry and Molecular Biology 121:1-2, pages 343-348.
Crossref
Crossref
Jing Shi, Xiaoyu Zhang, Zhongjun Ma, Min Zhang & Fang Sun. (2010) Characterization of Aromatase Binding Agents from the Dichloromethane Extract of Corydalis yanhusuo Using Ultrafiltration and Liquid Chromatography Tandem Mass Spectrometry. Molecules 15:5, pages 3556-3566.
Crossref
Crossref
Debashis Ghosh, Jennifer Griswold, Mary Erman & Walter Pangborn. (2010) X-ray structure of human aromatase reveals an androgen-specific active site. The Journal of Steroid Biochemistry and Molecular Biology 118:4-5, pages 197-202.
Crossref
Crossref
Jiaqi Fu, Amy M. Weise, Josie L. Falany, Charles N. Falany, Bryan J. Thibodeau, Fred R. Miller, Thomas A. Kocarek & Melissa Runge-Morris. (2009) Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Research and Treatment 120:1, pages 35-45.
Crossref
Crossref
Aruna V. Krishnan, Srilatha Swami, Lihong Peng, Jining Wang, Jacqueline Moreno & David Feldman. (2010) Tissue-Selective Regulation of Aromatase Expression by Calcitriol: Implications for Breast Cancer Therapy. Endocrinology 151:1, pages 32-42.
Crossref
Crossref
E. Shelley Hwang & Eric Jelin. 2011. Breast Surgical Techniques and Interdisciplinary Management. Breast Surgical Techniques and Interdisciplinary Management
717
729
.
Annamaria Lilienkampf, Sampo Karkola, Sari Alho-Richmond, Pasi Koskimies, Nina Johansson, Kaisa Huhtinen, Kimmo Vihko & Kristiina Wähälä. (2009)
Synthesis and Biological Evaluation of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitors Based on a Thieno[2,3-
d
]pyrimidin-4(3
H
)-one Core
. Journal of Medicinal Chemistry 52:21, pages 6660-6671.
Crossref
Crossref
Marcy J. Balunas, Bin Su, Soedarsono Riswan, Harry H.S. Fong, Robert W. Brueggemeier, John M. Pezzuto & A. Douglas Kinghorn. (2009) Isolation and characterization of aromatase inhibitors from Brassaiopsis glomerulata (Araliaceae). Phytochemistry Letters 2:1, pages 29-33.
Crossref
Crossref
Paul J. Fitzgerald. (2009) Is norepinephrine an etiological factor in some types of cancer?. International Journal of Cancer 124:2, pages 257-263.
Crossref
Crossref
Marcy J. Balunas, Bin Su, Robert W. Brueggemeier & A. Douglas Kinghorn. (2008)
Xanthones from the Botanical Dietary Supplement Mangosteen (
Garcinia mangostana
) with Aromatase Inhibitory Activity
. Journal of Natural Products 71:7, pages 1161-1166.
Crossref
Crossref
Udayan Dutta & Kartikeya Pant. (2007) Aromatase inhibitors: past, present and future in breast cancer therapy. Medical Oncology 25:2, pages 113-124.
Crossref
Crossref
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo & Masakazu Toi. (2008) Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. Cancer Letters 262:2, pages 232-238.
Crossref
Crossref
Sampo Karkola, Annamaria Lilienkampf & Kristiina Wähälä. (2008) A 3D QSAR Model of 17β-HSD1 Inhibitors Based on a Thieno[2,3-d]pyrimidin-4(3H)-one Core Applying Molecular Dynamics Simulations and Ligand–Protein Docking. ChemMedChem 3:3, pages 461-472.
Crossref
Crossref
Margarida Cepa, Georgina Correia-da-Silva, Elisiário J. Tavares da Silva, Fernanda M.F. Roleira, Yanyan Hong, Shiuan Chen & Natércia A. Teixeira. (2008) Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids. Biological Chemistry 389:9.
Crossref
Crossref
Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos, Filitsa A. Badra & Athanasios G. Papavassiliou. (2007) SUMO and estrogen receptors in breast cancer. Breast Cancer Research and Treatment 107:2, pages 195-210.
Crossref
Crossref
David C Lamb, Michael R Waterman, Steven L Kelly & F Peter Guengerich. (2007) Cytochromes P450 and drug discovery. Current Opinion in Biotechnology 18:6, pages 504-512.
Crossref
Crossref
Rebecca B. Riggins, Randy S. Schrecengost, Michael S. Guerrero & Amy H. Bouton. (2007) Pathways to tamoxifen resistance. Cancer Letters 256:1, pages 1-24.
Crossref
Crossref
Hope S. Rugo. (2007) Hormonal Therapy for Advanced Breast Cancer. Hematology/Oncology Clinics of North America 21:2, pages 273-291.
Crossref
Crossref